SBL
CLB icon

Sargent Bickham Lagudis’s Core Laboratories CLB Stock Holding History

Sargent Bickham Lagudis’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$4K – 798
2020
Q2 		$4K Sell
200
-358
-64% -$6.42K ﹤0.01% 658
2020
Q1 		$6K Buy
558
+200
+56% +$5.59K ﹤0.01% 618
2019
Q4 		$13K Sell
358
-371
-51% -$16.7K ﹤0.01% 577
2019
Q3 		$34K Sell
729
-1,535
-68% -$71.4K ﹤0.01% 393
2019
Q2 		$118K Hold
2,264
– – 0.01% 260
2019
Q1 		$156K Sell
2,264
-52
-2% -$3.49K 0.02% 238
2018
Q4 		$138K Hold
2,316
– – 0.02% 235
2018
Q3 		$268K Hold
2,316
– – 0.03% 183
2018
Q2 		$292K Hold
2,316
– – 0.04% 166
2018
Q1 		$251K Hold
2,316
– – 0.03% 181
2017
Q4 		$254K Hold
2,316
– – 0.03% 192
2017
Q3 		$229K Hold
2,316
– – 0.03% 203
2017
Q2 		$235K Hold
2,316
– – 0.03% 193
2017
Q1 		$268K Hold
2,316
– – 0.03% 182
2016
Q4 		$278K Hold
2,316
– – 0.04% 169
2016
Q3 		$260K Sell
2,316
-153
-6% -$17.6K 0.04% 182
2016
Q2 		$306K Hold
2,469
– – 0.05% 163
2016
Q1 		$278K Buy
+2,469
New +$257K 0.04% 173

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sargent Bickham Lagudis's CLB Position: Q3 2020 in Review

Sargent Bickham Lagudis sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 200 shares — an estimated $4K sold.

Sargent Bickham Lagudis first reported a position in CLB in Q1 2016 and held it in 18 quarters. The position peaked at $306K in Q2 2016. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Sargent Bickham Lagudis reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 200 Core Laboratories shares in Q3 2020, an estimated $4K.
  • Sargent Bickham Lagudis first reported a position in Core Laboratories in Q1 2016 and held it in 18 quarters.
  • Sargent Bickham Lagudis's Core Laboratories position peaked at $306K in Q2 2016.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2020, filed 1 Sep 2021.